Novavax - 24 Year Stock Price History | NVAX

Historical daily share price chart and data for Novavax since 1995 adjusted for splits. The latest closing stock price for Novavax as of December 13, 2019 is 4.03.
  • The all-time high Novavax stock closing price was 300.60 on October 09, 2001.
  • The Novavax 52-week high stock price is 48.80, which is 1110.9% above the current share price.
  • The Novavax 52-week low stock price is 3.54, which is 12.2% below the current share price.
  • The average Novavax stock price for the last 52 weeks is 13.55.
Novavax Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 12.4713 39.4000 46.8000 3.6900 4.0300 -89.05%
2018 35.1765 26.0000 49.6000 23.4000 36.8000 48.39%
2017 23.4596 25.4000 32.6000 14.6800 24.8000 -1.59%
2016 95.1524 157.6000 166.8000 23.6000 25.2000 -84.98%
2015 179.2758 115.2000 282.8000 114.8000 167.8000 41.48%
2014 98.5063 104.2000 133.0000 73.8000 118.6000 15.82%
2013 52.5332 39.4000 103.2000 35.0000 102.4000 170.90%
2012 33.0187 27.6000 47.8000 23.2000 37.8000 50.00%
2011 39.4103 51.4000 59.2000 23.6000 25.2000 -48.15%
2010 47.0562 56.2000 60.4000 40.2000 48.6000 -8.65%
2009 56.0539 40.4000 133.0000 11.2000 53.2000 40.74%
2008 51.5972 65.2000 70.6000 27.6000 37.8000 -43.24%
2007 67.2954 77.4000 90.0000 51.8000 66.6000 -18.78%
2006 93.8374 77.6000 166.2000 56.8000 82.0000 6.49%
2005 42.3058 64.8000 110.6000 14.8000 77.0000 18.10%
2004 92.4413 120.2000 138.4000 58.6000 65.2000 -45.67%
2003 102.6305 56.0000 164.4200 52.7800 120.0000 130.77%
2002 120.5912 272.4000 272.4000 37.2000 52.0000 -81.56%
2001 213.7363 168.2000 300.6000 138.8000 282.0000 65.88%
2000 152.4373 115.0000 231.2000 95.0000 170.0000 51.25%
1999 77.3056 40.0000 118.8000 38.8000 112.4000 189.69%
1998 66.5198 101.2000 116.2000 27.6000 38.8000 -61.20%
1997 87.7589 67.6000 115.0000 60.0000 100.0000 45.35%
1996 98.8654 80.0000 162.4000 60.0000 68.8000 -8.27%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.107B $0.034B
NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as vehicles for the delivery of a wide variety of drugs and other therapeutic products, including certain hormones, anti-bacterial and anti-viral products and vaccine adjuvants.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.667B 16.20
CSL (CSLLY) Australia $87.267B 0.00
Gilead Sciences (GILD) United States $83.209B 10.31
Vertex Pharmaceuticals (VRTX) United States $56.311B 57.47
Biogen (BIIB) United States $53.561B 9.19
Illumina (ILMN) United States $47.734B 52.37
Regeneron Pharmaceuticals (REGN) United States $41.329B 18.10
Alexion Pharmaceuticals (ALXN) United States $24.435B 12.07
Incyte (INCY) United States $19.711B 45.76
Seattle Genetics (SGEN) United States $19.516B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.617B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.401B 0.00
Genmab (GNMSF) Denmark $13.473B 59.51
Alnylam Pharmaceuticals (ALNY) United States $13.127B 0.00
Galapagos (GLPG) Belgium $11.469B 29.55
Exact Sciences (EXAS) United States $11.321B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.822B 51.94
Sarepta Therapeutics (SRPT) United States $9.843B 0.00
QIAGEN (QGEN) Netherlands $9.282B 30.26
Amarin (AMRN) Ireland $8.616B 0.00
BeiGene (BGNE) Cayman Islands $8.453B 0.00
Bio-Techne Corp (TECH) United States $8.119B 54.34
BioNTech SE (BNTX) Germany $7.342B 0.00
Guardant Health (GH) United States $7.127B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.829B 0.00
Medicines (MDCO) United States $6.714B 0.00
Reata Pharmaceuticals (RETA) United States $6.259B 0.00
Moderna (MRNA) United States $6.205B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.151B 15.64
ARGENX SE-ADR (ARGX) Netherlands $5.987B 0.00
Exelixis (EXEL) United States $5.415B 15.23
Bluebird Bio (BLUE) United States $4.966B 0.00
Ascendis Pharma (ASND) Denmark $4.854B 0.00
Repligen (RGEN) United States $4.612B 83.58
China Biologic Products (CBPO) China $4.605B 25.94
MorphoSys AG (MOR) Germany $4.485B 0.00
Mirati Therapeutics (MRTX) United States $4.427B 0.00
Spark Therapeutics (ONCE) United States $4.266B 0.00
Immunomedics (IMMU) United States $3.997B 0.00
Adaptive Biotechnologies (ADPT) United States $3.755B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.737B 0.00
Blueprint Medicines (BPMC) United States $3.653B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.608B 0.00
Alkermes (ALKS) Ireland $3.287B 0.00
UniQure (QURE) Netherlands $3.227B 0.00
MyoKardia (MYOK) United States $3.083B 0.00
Genmab (GMAB) Denmark $2.854B 5.88
Halozyme Therapeutics (HALO) United States $2.781B 0.00
NeoGenomics (NEO) United States $2.758B 146.78
Emergent Biosolutions (EBS) United States $2.683B 26.65
Acceleron Pharma (XLRN) United States $2.679B 0.00
Zai Lab (ZLAB) China $2.502B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.469B 0.00
Amicus Therapeutics (FOLD) United States $2.403B 0.00
Arena Pharmaceuticals (ARNA) United States $2.356B 5.48
RA PHARMCTL INC (RARX) United States $2.225B 0.00
Insmed (INSM) United States $2.074B 0.00
Myriad Genetics (MYGN) United States $1.903B 28.11
Ligand Pharmaceuticals (LGND) United States $1.862B 35.82
Dicerna Pharmaceuticals (DRNA) United States $1.833B 0.00
Denali Therapeutics (DNLI) United States $1.815B 0.00
Akcea Therapeutics (AKCA) United States $1.812B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.656B 0.00
Zymeworks (ZYME) Canada $1.654B 0.00
Principia Biopharma (PRNB) United States $1.630B 0.00
Epizyme (EPZM) United States $1.613B 0.00
REGENXBIO (RGNX) United States $1.606B 0.00
Editas Medicine (EDIT) United States $1.534B 0.00
Arvinas (ARVN) United States $1.435B 0.00
Fate Therapeutics (FATE) United States $1.420B 0.00
Innoviva (INVA) United States $1.394B 4.11
Alector (ALEC) United States $1.393B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.371B 0.00
Coherus BioSciences (CHRS) United States $1.299B 0.00
WAVE Life Sciences (WVE) Singapore $1.289B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.188B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Athenex (ATNX) United States $1.128B 0.00
Zealand Pharma (ZEAL) Denmark $1.015B 0.00
Pharming Group (PHGUF) Netherlands $1.013B 0.00
Sangamo Therapeutics (SGMO) United States $0.987B 0.00
Codexis (CDXS) United States $0.925B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.892B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.892B 7.50
Achillion Pharmaceuticals (ACHN) United States $0.877B 0.00
Twist Bioscience (TWST) United States $0.870B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.841B 0.00
Intellia Therapeutics (NTLA) United States $0.807B 0.00
Vericel (VCEL) United States $0.788B 294.00
MiMedx (MDXG) United States $0.782B 0.00
DBV Technologies S.A (DBVT) France $0.780B 0.00
Anika Therapeutics (ANIK) United States $0.758B 24.61
ANI Pharmaceuticals (ANIP) United States $0.739B 12.60
Heska (HSKA) United States $0.732B 186.92
Revance Therapeutics (RVNC) United States $0.721B 0.00
Intra-Cellular Therapies (ITCI) United States $0.709B 0.00
Clovis Oncology (CLVS) United States $0.705B 0.00
Adverum Biotechnologies (ADVM) United States $0.681B 0.00
Cellectis S.A (CLLS) France $0.677B 0.00
UROGEN PHARMA (URGN) United States $0.676B 0.00
Mesoblast (MESO) Australia $0.670B 0.00
Sorrento Therapeutics (SRNE) United States $0.670B 0.00
Cara Therapeutics (CARA) United States $0.663B 0.00
Cytokineticsorporated (CYTK) United States $0.629B 0.00
GENFIT S.A (GNFT) France $0.628B 0.00
Retrophin (RTRX) United States $0.616B 0.00
Kadmon Holdings (KDMN) United States $0.613B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
PHARMA MAR SA (PHMMF) Spain $0.584B 0.00
Dynavax Technologies (DVAX) United States $0.580B 0.00
AC Immune SA (ACIU) Switzerland $0.577B 13.34
BioDelivery Sciences (BDSI) United States $0.573B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Agenus (AGEN) United States $0.527B 0.00
Precision BioSciences (DTIL) United States $0.523B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.516B 3.57
Prothena (PRTA) Ireland $0.513B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.508B 0.00
Stemline Therapeutics (STML) United States $0.504B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AnaptysBio (ANAB) United States $0.427B 0.00
Avid Bioservices (CDMO) United States $0.410B 0.00
Arcus Biosciences (RCUS) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.395B 0.00
Bellus Health (BLU) Canada $0.387B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.60
AMAG Pharmaceuticals (AMAG) United States $0.378B 0.00
OSMOTICA PHARM (OSMT) United States $0.370B 0.00
Puma Biotechnology (PBYI) United States $0.365B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.344B 0.00
Gritstone Oncology (GRTS) United States $0.331B 0.00
Starpharma Holdings (SPHRY) Australia $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.325B 0.00
Cellular Biomedicine (CBMG) United States $0.321B 0.00
Kindred Biosciences (KIN) United States $0.319B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.314B 0.00
Cue Biopharma (CUE) United States $0.312B 0.00
Scholar Rock Holding (SRRK) United States $0.305B 0.00
Geron (GERN) United States $0.300B 0.00
Seres Therapeutics (MCRB) United States $0.294B 0.00
Kamada (KMDA) Israel $0.294B 8.58
Compugen (CGEN) Israel $0.290B 0.00
NantKwest (NK) United States $0.283B 0.00
MannKind (MNKD) United States $0.279B 0.00
ChromaDex (CDXC) United States $0.275B 0.00
Inovio Pharmaceuticals (INO) United States $0.272B 0.00
Exicure (XCUR) United States $0.261B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
Albireo Pharma (ALBO) United States $0.257B 0.00
IVERIC Bio (ISEE) United States $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.242B 0.00
Senesco Technologies (ELOX) United States $0.239B 0.00
Theratechnologies (THTX) Canada $0.234B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.231B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.227B 0.00
Biofrontera AG (BFRA) Germany $0.221B 0.00
Proteostasis Therapeutics (PTI) United States $0.217B 0.00
Spero Therapeutics (SPRO) United States $0.212B 0.00
XOMA (XOMA) United States $0.208B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Protagonist Therapeutics (PTGX) United States $0.199B 0.00
Syros Pharmaceuticals (SYRS) United States $0.195B 0.00
Cerecor (CERC) United States $0.195B 0.00
Affimed (AFMD) Germany $0.194B 0.00
Athersys (ATHX) United States $0.194B 0.00
ARAVIVE, INC (ARAV) United States $0.190B 0.00
Abeona Therapeutics (ABEO) United States $0.187B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
Mersana Therapeutics (MRSN) United States $0.178B 0.00
VBI Vaccines (VBIV) United States $0.174B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.158B 0.00
Five Prime Therapeutics (FPRX) United States $0.157B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Windtree Therapeutics (WINT) United States $0.151B 0.00
Alcobra (ARCT) United States $0.150B 0.00
Aptinyx (APTX) United States $0.143B 0.00
Fortress Biotech (FBIO) United States $0.139B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.138B 0.00
Arsanis (XFOR) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Prometic Life Sciences (LMNL) Canada $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
Arbutus Biopharma (ABUS) Canada $0.132B 0.00
TELA Bio (TELA) United States $0.128B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.128B 0.00
Nicox SA (NICXF) France $0.125B 0.00
Enzo Biochem (ENZ) United States $0.125B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.109B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.108B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.102B 0.00
Emmaus Life Sciences (EMMA) United States $0.101B 0.00
Strongbridge Biopharma (SBBP) United States $0.100B 2.67
Verastem (VSTM) United States $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Aduro Biotech (ADRO) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Acorda Therapeutics (ACOR) United States $0.085B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
OvaScience (MLND) United States $0.083B 0.00
Vaccinex (VCNX) United States $0.082B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Trevena (TRVN) United States $0.069B 0.00
Liquidia Technologies (LQDA) United States $0.068B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.061B 0.00
Catalyst Biosciences (CBIO) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.051B 0.00
Curis (CRIS) United States $0.050B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
Checkpoint Therapeutics (CKPT) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Orgenesis (ORGS) United States $0.046B 2.97
DiaMedica Therapeutics (DMAC) United States $0.045B 0.00
AquaBounty Technologies (AQB) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.041B 0.00
Alimera Sciences (ALIM) United States $0.041B 0.00
Celsion (CLSN) United States $0.037B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.035B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.030B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
BioCardia (BCDA) United States $0.028B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Soligenix (SNGX) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Entera Bio (ENTX) Israel $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
CollPlant Holdings (CLGN) Israel $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Aytu Bioscience (AYTU) United States $0.019B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
AEterna Zentaris (AEZS) United States $0.016B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Advaxis (ADXS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.003B 0.00